Gossamer Bio GOSS
NASDAQ GOSS
$9.79 +0.21 (+2.19%)
At close: Oct 21, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Preferred Stock Liabilities (2018)

Updated

Gossamer Bio's Preferred Stock Liabilities was $338.37 million in Q4 2018, unchanged from the prior quarter.

Analysis

Gossamer Bio (GOSS) Preferred Stock Liabilities (2018) Analysis & Trends

From Q1 2018 onward, Gossamer Bio has reported Preferred Stock Liabilities for 4 quarters.

  • Per Business Quant data, GOSS's Preferred Stock Liabilities in the three quarters before Q4 2018 was $338.37 million (Q3 2018), $108.82 million (Q2 2018) and $107.27 million (Q1 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Gossamer Bio 39.44 Mn -433.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 338.37 Mn
Sep 30, 2018 338.37 Mn
Jun 30, 2018 108.82 Mn
Mar 31, 2018 107.27 Mn
API Access

Gossamer Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=GOSS&period=max&api_key=YOUR_API_KEY